Antifungal agents have greatly contributed to the improvement of public health. Nevertheless, antifungal resistant pathogens have increased during the past decade, becoming a serious concern. Candida albicans has been the most extensively studied pathogen in antifungal resistance because of their morbidity and mortality associated with infections in immunocompromised patients. This review describes the antifungal mechanims of the azole fluconazole widely used for the prophylaxis and treatment of candidal infections. The specific molecular pathways occurring in fluconazole-resistance of C. albicans and some issues about new antifungal agents are also discussed.
Casalinuovo, I.A., Di Francesco, P., & Garaci, E. (2004). Fluconazole resistance in Candida albicans: a review of mechanisms. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 8(2), 69-77.
Tipologia: | Articolo su rivista |
Citazione: | Casalinuovo, I.A., Di Francesco, P., & Garaci, E. (2004). Fluconazole resistance in Candida albicans: a review of mechanisms. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 8(2), 69-77. |
URL: | PMID: 15267120 |
IF: | Con Impact Factor ISI |
Lingua: | English |
Settore Scientifico Disciplinare: | Settore MED/07 - Microbiologia e Microbiologia Clinica |
Revisione (peer review): | Sì, ma tipo non specificato |
Tipo: | Articolo |
Rilevanza: | Rilevanza internazionale |
Stato di pubblicazione: | Pubblicato |
Data di pubblicazione: | 2004 |
Titolo: | Fluconazole resistance in Candida albicans: a review of mechanisms. |
Autori: | |
Autori: | Casalinuovo, IA; Di Francesco, P; Garaci, E |
Appare nelle tipologie: | 01 - Articolo su rivista |